Childhood cancer: the long-term costs of cure

Survival after childhood cancer has substantially improved over the past several decades, and more than 80% of children diagnosed with cancer in the USA now survive at least 5 years.1 This improvement comes at a cost, however, because the curative therapies used to achieve such successful survival p...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 2017-12, Vol.390 (10112), p.2530-2531
Main Authors: Fidler, Miranda M, Hawkins, Michael M
Format: Article
Language:English
Subjects:
Cancer
Cancer therapies
Child
Children
Childrens health
Chronic illnesses
Costs and Cost Analysis
Health risk assessment
Humans
Morbidity
Neoplasms
Side effects
Survivors
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Survival after childhood cancer has substantially improved over the past several decades, and more than 80% of children diagnosed with cancer in the USA now survive at least 5 years.1 This improvement comes at a cost, however, because the curative therapies used to achieve such successful survival proportions are associated with adverse late effects, with previous research finding increased risks of morbidity,2 poor health status,3 and premature mortality4 compared with sibling and population comparison groups.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(17)31755-5